Generic Drug Manufacturer Ranbaxy

MD 2013 Independent Pharmacies

DOJ False Claims Act

Penalty

$350 million

Outcome

Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statements to the FDA

Details

Generic Drug Manufacturer Ranbaxy — DOJ Enforcement (2013)

Outcome: Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statements to the FDA

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted.

Source: DOJ Press Release — Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statemen

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works